The Medical News

The Medical News

UVA, Novo Nordisk partner to develop virtual patient modeling for type 2 diabetes From an initial group of 2,042 residents of Olmsted County, 116 study participants with diabetes were matched 1:2 for age, hypertension, sex, coronary artery disease and diastolic dysfunction to 232 participants without diabetes. Over the 10-year follow-up period, 21% of participants with diabetes developed heart failure, independent of other causes. In comparison, only 12% of patients without diabetes developed heart failure. Cardiac death, heart attack and stroke were not statistically different in the study between the two groups. The study shows that diabetes is an independent risk factor for the development of heart failure in the community dwelling population. Furthermore, the outcome data support the concept of a diabetic cardiomyopathy. This research extends previous findings and demonstrates that even without a known cardiac structural abnormality and with a normal ejection fraction, diabetic patients are still at increased risk of developing heart failure as compared to their nondiabetic counterparts. The key takeaway is that diabetes mellitus alone is an independent risk factor for the development of heart failure. Our hope is that this study provides a strong foundation for further investigations into diabetes and heart failure. There is still much to learn and study in terms of this association and how to best diagnose and treat this condition." Dr. Horng Chen, cardiologist, Mayo Clinic Source: Mayo Clinic Journal reference: Klajda, M.D., et al. (2020) Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure. Mayo Clinic Proceedings . doi.org/10.1016/j.mayocp.2019.07.008 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More